Loading clinical trials...
Loading clinical trials...
Epidemiology of CoV-2 SARS Infections: Dynamics of Community Contamination in Children and Adults - Impact of Variants
Unlike other respiratory viruses such as influenza and RSV where the child is the essential reservoir and central vector of intrafamilial contamination, the child is likely to be a small player in the transmission of CoV2-CoRSA infection. This study aims to describe the age category of the first contact, within 14 days before the appearance of the first symptoms of the index case in order to describe the age categories of this first contaminant, globally, in the group of children and finally in the group of adults. This work is intended to provide food for discussion and to justify the distancing and containment measures imposed on children when their isolation has a deleterious impact that has now been established for some children.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Hôpital Femme Mère et enfant
Lyon, Auvergne-Rhône-Alpes, France
Start Date
June 22, 2021
Primary Completion Date
October 28, 2021
Completion Date
October 28, 2021
Last Updated
January 4, 2022
87
ACTUAL participants
Review of medical file
OTHER
Phone call interview
OTHER
Lead Sponsor
Hospices Civils de Lyon
NCT04637867
NCT04290780
NCT06379061
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions